ST天圣: 第六届董事会第十二次会议决议公告

Group 1 - The company held its 12th meeting of the 6th Board of Directors on June 23, 2025, with all 7 directors present, confirming compliance with relevant laws and regulations [1] - The board approved a guarantee for its wholly-owned subsidiary, Tian Sheng Pharmaceutical Group Chongqing Drug Research Institute Co., Ltd., with a unanimous vote of 7 in favor [1][2] - The board also approved a guarantee for another wholly-owned subsidiary, Chongqing Tianhuo Pharmaceutical Sales Co., Ltd., which will require further approval from the shareholders' meeting [2] - The board passed a resolution to amend the company's articles of association, which also requires shareholder approval [2] - A proposal to convene the company's second extraordinary general meeting of 2025 was approved unanimously by the board [2][3] Group 2 - The meeting was chaired by Chairman Liu Shuang, with attendance from supervisors and senior management [1] - The resolutions from the board meeting will be documented and made available for review [3]